company background image
EMBLA logo

Embla Medical hf CPSE:EMBLA Stock Report

Last Price

DKK 35.40

Market Cap

DKK 15.1b

7D

-4.1%

1Y

28.3%

Updated

18 Dec, 2024

Data

Company Financials +

Embla Medical hf.

CPSE:EMBLA Stock Report

Market Cap: DKK 15.1b

EMBLA Stock Overview

Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details

EMBLA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance5/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 13.6% below our estimate of its fair value

Earnings are forecast to grow 16.87% per year

Earnings grew by 32.1% over the past year

Risk Analysis

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

Embla Medical hf. Competitors

Ambu

CPSE:AMBU B

DKK 28.6b

Demant

CPSE:DEMANT

DKK 57.8b

NuVasive

NasdaqGS:NUVA

US$2.1b

Elekta

OM:EKTA B

SEK 23.6b

Price History & Performance

Summary of share price highs, lows and changes for Embla Medical hf
Historical stock prices
Current Share PriceDKK 35.40
52 Week HighDKK 38.00
52 Week LowDKK 26.00
Beta0.62
1 Month Change-1.39%
3 Month Change13.46%
1 Year Change28.26%
3 Year Change-17.00%
5 Year Change-31.40%
Change since IPO543.64%

Recent News & Updates

Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Dec 16
Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Nov 30
Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oct 25
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Oct 17
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Recent updates

Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Dec 16
Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Nov 30
Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oct 25
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Oct 17
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Oct 02
Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Apr 10
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Mar 23
Is Össur hf (CPH:OSSR) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Jan 21
Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 03
Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Nov 28
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

Sep 23
A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Aug 21
We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Jul 18
Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Jun 14
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

May 19
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 21
A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22
These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21
Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Aug 16
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Jun 16
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Jun 01
Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

May 08
Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Feb 22
Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Feb 03
Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Nov 25
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Oct 17
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Is Össur hf (CPH:OSSR) A Risky Investment?

Sep 28
Is Össur hf (CPH:OSSR) A Risky Investment?

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Aug 21
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Jul 11
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

May 28
Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

May 07
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Mar 25
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Shareholder Returns

EMBLADK Medical EquipmentDK Market
7D-4.1%-4.0%-2.2%
1Y28.3%2.2%7.9%

Return vs Industry: EMBLA exceeded the Danish Medical Equipment industry which returned 3% over the past year.

Return vs Market: EMBLA exceeded the Danish Market which returned 9% over the past year.

Price Volatility

Is EMBLA's price volatile compared to industry and market?
EMBLA volatility
EMBLA Average Weekly Movement3.2%
Medical Equipment Industry Average Movement3.7%
Market Average Movement4.3%
10% most volatile stocks in DK Market10.9%
10% least volatile stocks in DK Market2.6%

Stable Share Price: EMBLA has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: EMBLA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated.

Embla Medical hf. Fundamentals Summary

How do Embla Medical hf's earnings and revenue compare to its market cap?
EMBLA fundamental statistics
Market capDKK 15.11b
Earnings (TTM)DKK 492.19m
Revenue (TTM)DKK 5.99b

30.7x

P/E Ratio

2.5x

P/S Ratio

Is EMBLA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMBLA income statement (TTM)
RevenueUS$840.31m
Cost of RevenueUS$319.17m
Gross ProfitUS$521.13m
Other ExpensesUS$452.07m
EarningsUS$69.07m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)0.16
Gross Margin62.02%
Net Profit Margin8.22%
Debt/Equity Ratio50.7%

How did EMBLA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 11:40
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Embla Medical hf. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Benjamin SilverstoneABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored